Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Talha Shaikh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5104059044. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-021-10219-3↗
  2. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Co-author DOI 10.1097/coc.0000000000000227↗
  3. Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer. Co-author DOI 10.1016/j.prro.2015.11.005↗
  4. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. First author DOI 10.1016/j.prro.2015.04.004↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Parker Hoffman · 4 shared papers, 2015–2022 · strength 0.36
  2. Joshua E. Meyer · 4 shared papers, 2015–2022 · strength 0.36
  3. Steven J. Cohen · 4 shared papers, 2015–2022 · strength 0.36
  4. Lora S. Wang · 3 shared papers, 2015–2018 · strength 0.22
  5. Eddie Zhang · 1 shared paper, 2022 · strength 0.15
  6. Efrat Dotan · 1 shared paper, 2022 · strength 0.15
  7. Sanjay S. Reddy · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.